Physician profile
Nicholas Loafman
NPI 1598998288
$74,608.39
in general payments reported to CMS, 2019-2025
23 companies · $4,457 in 2025
The $4,457 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $7,818 · 2021: $19K · 2022: $251 · 2023: $1,207 · 2024: $2,354 · 2025: $4,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,031 · Food and Beverage: $2,986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,031.36 |
| Food and Beverage | $2,986.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $65,136.21 | 2019-2025 | Amistem, Gmk Sphere, Gmk Efficiency |
| Arthrex, INC. | $3,219.60 | 2024-2025 | |
| Smith+Nephew, INC. | $3,175.73 | 2019 | |
| Zak Ortho | $1,249.86 | 2025 | |
| Zimmer Biomet Holdings, INC. | $595.97 | 2021-2025 | Rosa, Avenir, Mymobility Platform |
| Stryker Corporation | $300.79 | 2020-2024 | Aequalis Flex Revive, Insignia, T2 Alpha |
| Medwest Associates | $286.97 | 2023 | |
| Endo Pharmaceuticals INC. | $144.63 | 2019-2020 | |
| Depuy Synthes Sales INC. | $126.46 | 2022-2023 | Na |
| Heron Therapeutics, INC. | $81.86 | 2021-2025 | Zynrelef |
| Avanos Medical | $43.12 | 2019 | |
| Orthofix Medical, INC. | $40.82 | 2022 | |
| Davol INC. | $38.69 | 2025 | Surgiphor |
| Bioventus LLC | $24.79 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $20.20 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $18.82 | 2019 | |
| Mallinckrodt Enterprises LLC | $18.56 | 2019 | |
| Medtronic USA, INC. | $15.56 | 2020 | |
| Amgen INC. | $14.97 | 2023 | Evenity, Prolia |
| Wright Medical Technology, INC. | $14.96 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.48 | 2022 | |
| Vericel Corporation | $12.71 | 2021 | |
| Linvatec Corporation | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Loafman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.